Trials / Enrolling By Invitation
Enrolling By InvitationNCT06699615
Assessing Perceptions of ML Explanations by Medical Oncologists
Survey of Medical Oncologists to Assess Trustworthiness of Various Approaches to AI Explainability for Prognostic Models
- Status
- Enrolling By Invitation
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 50 (estimated)
- Sponsor
- Abramson Cancer Center at Penn Medicine · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
The objective of this proposal is to conduct a vignette-based survey among practicing oncology clinicians who treat non-small cell lung cancer to assess the trustworthiness of explainable predictions from a neurosymbolic AI vs. State-of-the-art post-hoc explanatory algorithms, using simulated patient data.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Once time de-identified Qualtrics survey | Once time de-identified Qualtrics survey |
Timeline
- Start date
- 2024-12-02
- Primary completion
- 2028-04-15
- Completion
- 2028-04-15
- First posted
- 2024-11-21
- Last updated
- 2026-04-06
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT06699615. Inclusion in this directory is not an endorsement.